FCGR2A and neoplasm: Recently, a study using the same model of anti-huCD20 mAb treatment of tumors in transgenic mice expressing human FcγR has demonstrated that the induction of anti-tumor adaptive immunity is dependent on the expression of FcγRIIA on DC and on FcyRIIIA-mediated ADCC (15).